ClinConnect ClinConnect Logo
Search / Trial NCT03628313

Valvular Aortic Stenosis Prognosis Study

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Aug 9, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Echoacrdiography Echo Doppler Aortic Valve Stenosis Prognosis

ClinConnect Summary

The Valvular Aortic Stenosis Prognosis Study is looking to understand the long-term outcomes for patients with a condition called aortic stenosis, which is a narrowing of the heart's aortic valve. This study will examine both patients who have symptoms and those who do not, to better understand how this condition affects them over time. Researchers will use heart ultrasound tests (called echocardiograms) to gather important information about the condition and how it might progress.

If you're between the ages of 65 and 74 and have been diagnosed with aortic stenosis in the past or have had an echocardiogram showing a narrowing of the aortic valve, you might be eligible to participate. However, you won't be able to join if you previously had surgery on your aortic valve or if you choose not to participate. For those who do join, the study will involve reviewing medical records and echocardiogram results collected over several years, helping to provide valuable insights into this common heart condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Retrospectively, all patients examined from January 1, 2000 to November 2014 will be included in the echocardiography laboratory whose objective examination is a narrowing of the aortic valve (maximum transaortic velocity ≥2.5 m / s).
  • Aortic stenosis may be known in the past.
  • Exclusion Criteria:
  • Refusal of the patient to participate in the study.
  • Patients who have previously had aortic valve surgery before being examined in the echocardiography laboratory.
  • Patients who can not be contacted or who do not respond will not be included in the database.

About Centre Hospitalier Universitaire, Amiens

The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.

Locations

Amiens, , France

Patients applied

0 patients applied

Trial Officials

Christophe TRIBOUILLOY, MD, PhD

Principal Investigator

CHU AMIENS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials